These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin. Senger DR; Ledbetter SR; Claffey KP; Papadopoulos-Sergiou A; Peruzzi CA; Detmar M Am J Pathol; 1996 Jul; 149(1):293-305. PubMed ID: 8686754 [TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. Murohara T; Horowitz JR; Silver M; Tsurumi Y; Chen D; Sullivan A; Isner JM Circulation; 1998 Jan 6-13; 97(1):99-107. PubMed ID: 9443437 [TBL] [Abstract][Full Text] [Related]
13. Keratinocyte-derived vascular permeability factor (vascular endothelial growth factor) is a potent mitogen for dermal microvascular endothelial cells. Detmar M; Yeo KT; Nagy JA; Van de Water L; Brown LF; Berse B; Elicker BM; Ledbetter S; Dvorak HF J Invest Dermatol; 1995 Jul; 105(1):44-50. PubMed ID: 7615975 [TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor/scatter factor (HGF/SF) induces vascular permeability factor (VPF/VEGF) expression by cultured keratinocytes. Gille J; Khalik M; König V; Kaufmann R J Invest Dermatol; 1998 Dec; 111(6):1160-5. PubMed ID: 9856833 [TBL] [Abstract][Full Text] [Related]
15. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines. Bancroft CC; Chen Z; Yeh J; Sunwoo JB; Yeh NT; Jackson S; Jackson C; Van Waes C Int J Cancer; 2002 Jun; 99(4):538-48. PubMed ID: 11992543 [TBL] [Abstract][Full Text] [Related]